List of medicines currently in PRIME scheme
List of medicines currently in PRIME scheme
List of medicines currently in PRIME scheme
Recommendations on eligibility to PRIME scheme adopted at the CHMP meeting of 19-22 May 2025
Draft guideline on good pharmacovigilance practices (GVP): Module XVI Addendum I – Educational materials
Human medicines European public assessment report (EPAR): Upstaza, eladocagene exuparvovec, Date of authorisation: 18/07/2022, Revision: 8, Status: Authorised
Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, Date of authorisation: 20/06/2024, Revision: 4, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Hepizovac, epizootic haemorrhagic disease vaccine (inactivated), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Prazivetin, praziquantel, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Prevestrus vet, finrozole, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Nobilis Multriva IBm+ND+EDS, infectious bronchitis,Newcastle disease,egg drop syndrome virus vaccine (inactivated), Status: Authorised
Human medicines European public assessment report (EPAR): Prasugrel Viatris (previously Prasugrel Mylan), prasugrel, Date of authorisation: 15/05/2018, Revision: 12, Status: Authorised